Merck won a crucial legal victory on Thursday and removed a cloud that had been hanging over the US drugmaker and its investors over the withdrawn painkiller Vioxx.
The New Jersey Supreme Court overturned lower court rulings granting class-action status for a lawsuit representing insurance companies and healthcare systems that bought Vioxx for patients.
